Health Care

Research-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) announced Monday it has named Daniel O'Day as its chairman of the board and CEO, effective March 1. What Happened O'Day joins Gilead after more than three decades of experience at Roche Holdings AG Basel ADR (OTC...

Walgreens Boots Alliance Inc (NASDAQ: WBA) and FedEx Corporation (NYSE: FDX) last week announced the launch of a nationwide next-day delivery service under which FedEx will deliver prescription drugs from Walgreens' pharmacies to patient locations. Walgreens has begun a same-day...

Biotechs Axsome Therapeutics Inc (NASDAQ: AXSM) and Axovant Sciences Ltd (NASDAQ: AXON) were taking diverging paths Monday.  While shares of Axsome surged higher by nearly 8 percent, Axovant shares were down by more than 25 percent at the time of publication.  Positive Interim Results...

The landscape of thematic exchange traded funds, or those funds offering laser focus on specific investment niches and themes, are burgeoning part of the overall ETF universe. These days, investors can tap themes ranging from artificial intelligence to electric vehicles to quantum computing via...

Recreational cannabis sales continue to disrupt medical marijuana markets, which are morphing into merged regulatory regimes — just as GreenWave Advisors founder and managing partner Matt Karnes predicted almost two years ago. The most recent sales figures from Colorado, California and...

New Frontier Data's newly released 2018-2019 Cannabis Consumer Report: Archetypes, Preferences & Trends is based on survey responses from more than 3,000 U.S. adult consumers about why they use cannabis, where they get it, how they consume it, and their views about it in their...

Bank of America Merrill Lynch doubled down on its bullish thesis for GW Pharmaceuticals plc (NASDAQ: GWPH) and its flagship Epidiolex drug after attending the American Epilepsy Society's annual meeting. The Analyst Analysts Tazeen Ahmad maintained a Buy on GW Pharma with a $190 price...

This powerful video shows you, step-by-step, how and why cannabis works so well for PTSD. Get actionable tips on how to safely get started with cannabis, which types of cannabis to focus on, and even how this plant could be used to potentially prevent PTSD in the first place. This video was...

Investors looking for stocks that are fully "tariff-proof" should look at companies that derive the vast majority of their revenue domestically with a focus on the "strong consumer," Strategic Wealth Partners CEO said during a recent CNBC "Trading Nation" segment...

UnitedHealth Group Inc. (NYSE: UNH) hosted an investor day Tuesday highlighting the company’s growth, special technologies and 2019 guidance. The Analysts Morgan Stanley analyst Zack Sopcak reiterated an Overweight rating on UnitedHealth and $308 price target. Wells Fargo analyst Peter Costa...

CVS Health Corp (NYSE: CVS) and Aetna Inc (NYSE: AET) on Monday received the final state approval for their $69 billion merger, and CVS said it expects to the deal to close this week. CVS stock has dramatically lagged the S&P 500 in the past three years, but analysts love the company’s...

Health care investors are entering both the final stretch of 2018 and the final weeks of a GOP-controlled House of Representatives. Height Capital Markets analyst Andrea Harris surveyed nine potential health care catalysts that investors should be watching between now and the end of December...

Is cannabis a better alternative to ADHD drugs like Adderall or Ritalin? Robbin Lynn and Michele Ross explore the science behind why cannabis may be the healthier, more effective option. This video was originally posted on Green Flower.

A Canaccord Genuity analyst came away from a meeting with Mallinckrodt PLC (NYSE: MNK)'s executive team with an upbeat forecast for the pharma company's near-term prospects.  The Analyst Analyst Dewey Steadman upgraded Mallinckrodt from Hold to Buy and increased the price target...